β-adrenergic receptor blockade modulates Bcl-Xs expression and reduces apoptosis in failing myocardium

被引:66
作者
Prabhu, SD
Wang, GW
Luo, JZ
Gu, Y
Ping, PP
Chandrasekar, B
机构
[1] Univ Louisville, Dept Med, Hlth Sci Ctr, Louisville, KY 40292 USA
[2] Univ Louisville, Dept Physiol & Biophys, Hlth Sci Ctr, Louisville, KY 40292 USA
[3] VA Med Ctr, Med Serv, Louisville, KY USA
[4] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78284 USA
关键词
heart failure; beta-adrenergic antagonists; apoptosis; cell signaling; Bcl-X-s;
D O I
10.1016/S0022-2828(03)00052-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms by which beta-adrenergic receptor (beta-AR) blockade modulates apoptosis in heart failure (HF) are unclear. We examined the impact of beta-AR blockade with metoprolol on myocardial remodeling, apoptosis, pro-apoptotic (Fas, Fas ligand, Bax, and Bcl-X-s) and anti-apoptotic (Bcl-X(L)and Bcl-2) gene expression, and Bcl-X-L and Bcl-Xs protein in post-infarction HF in rats. In untreated rats, there was significant (P < 0.001) LV dilatation and systolic dysfunction compared to sham. Myocardial apoptosis was significantly increased (P < 0.005). Fas, Bax, and Bcl-2 mRNA expression was unchanged. However, Fas ligand mRNA and Bcl-X-s mRNA and protein, all undetectable in sham, were markedly elevated (P < 0.001), whereas Bcl-X-L mRNA and protein was unchanged. Immunohistochemistry confirmed increased Bcl-X-s staining in failing myocardium, with unchanged Bcl-X-L. Metoprolol treatment resulted in: (1) improved LV remodeling (P < 0.025), (2) reduced myocardial apoptosis (P < 0.005), and (3) selective reduction in myocardial Bcl-X-s expression (P < 0.001) without change in Fas, Fas ligand, Bax, Bcl-2, or Bcl-X-L. Studies in isolated rat myocytes revealed that prolonged isoproterenol (ISO) stimulation significantly increased Bcl-X-s protein, reducing the Bcl-X-L/X-s ratio and myocyte survival (P < 0.005). ISO-induced Bcl-X-s expression was significantly attenuated (P < 0.001) by both metoprolol and CGP20712A, a beta(1)-AR selective antagonist, but not by ICI 118,55 1, a beta(2)-AR selective antagonist. We conclude that adrenergic activation, such as occurs in HF, increases pro-apoptotic Bcl-X-s expression via the beta(1)-AR. beta-AR blockade in HF reduces myocardial apoptosis; attenuation of Bcl-X-s expression may be one mechanism underlying this effect. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 35 条
[21]   Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes [J].
Leri, A ;
Liu, Y ;
Malhotra, A ;
Li, Q ;
Stiegler, P ;
Claudio, PP ;
Giordano, A ;
Kajstura, J ;
Hintze, TH ;
Anversa, P .
CIRCULATION, 1998, 97 (02) :194-203
[22]   Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell [J].
Leri, A ;
Claudio, PP ;
Li, Q ;
Wang, XW ;
Reiss, K ;
Wang, SG ;
Malhotra, A ;
Kajstura, J ;
Anversa, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1326-1342
[23]   Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents [J].
Lowes, BD ;
Gilbert, EM ;
Abraham, WT ;
Minobe, WA ;
Larrabee, P ;
Ferguson, D ;
Wolfel, EE ;
Lindenfeld, J ;
Tsvetkova, T ;
Robertson, AD ;
Quaife, RA ;
Bristow, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) :1357-1365
[24]   Bcl-x(S) antagonizes the protective effects of Bcl-x(L) [J].
Minn, AJ ;
Boise, LH ;
Thompson, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6306-6312
[25]   Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression [J].
Murray, DR ;
Prabhu, SD ;
Chandrasekar, B .
CIRCULATION, 2000, 101 (20) :2338-2341
[26]  
Murray DR, 2001, CIRCULATION, V104, P498
[27]   Apoptosis in myocytes in end-stage heart failure [J].
Narula, J ;
Haider, N ;
Virmani, R ;
DiSalvo, TG ;
Kolodgie, FD ;
Hajjar, RJ ;
Schmidt, U ;
Semigran, MJ ;
Dec, GW ;
Khaw, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16) :1182-1189
[28]   Plasma fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure [J].
Nishigaki, K ;
Minatoguchi, S ;
Seishima, M ;
Asano, K ;
Noda, T ;
Yasuda, N ;
Sano, H ;
Kumada, H ;
Takemura, M ;
Noma, A ;
Tanaka, T ;
Watanabe, S ;
Fujiwara, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (06) :1214-1220
[29]   Apoptosis in the failing human heart [J].
Olivetti, G ;
Abbi, R ;
Quaini, F ;
Kajstura, J ;
Cheng, W ;
Nitahara, JA ;
Quaini, E ;
DiLoreto, C ;
Beltrami, CA ;
Krajewski, S ;
Reed, JC ;
Anversa, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1131-1141
[30]   CULTURING OF CALCIUM STABLE ADULT CARDIAC MYOCYTES [J].
PIPER, HM ;
PROBST, I ;
SCHWARTZ, P ;
HUTTER, FJ ;
SPIECKERMANN, PG .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1982, 14 (07) :397-412